Expert Insights On Decentralized Trials
-
Closing The Gender Gap In Clinical Trials With Digital Devices
8/15/2025
For decades, women have been underrepresented in clinical trials — a gap that’s not just unfortunate but dangerous. Digital devices might be the difference maker, says research physician Anita Phung, MRGCP, MRCP, MBBS, BSc (Hons).
-
Ask An Expert Before Shredding Your Mobile Device CAPEX
8/14/2025
Tasked with buying your company's mobile devices and not sure where to start? Discover the questions you should ask and the information you need to know before consulting an expert.
-
Can Digital Endpoints Really Accelerate Clinical Trials?
8/8/2025
Digital biomarkers are quickly and quietly becoming the digital revolution needed to make clinical trials quicker and more data rich. Discover how they are being used in clinical trials right now.
-
U.S. Tariffs And Their Tenuous Impact On Clinical Trials
6/10/2025
RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.
-
Decentralized Clinical Trials: Embracing The FDA's 2024 Final Guidance
4/16/2025
In Sept. 2024, the FDA unveiled a final guidance aimed at advancing decentralized clinical trials. This article shares a summary, describes the differences from the 2023 draft guidance, and provides helpful insight for sponsors.
-
Japan's Adoption Of DCTs Is Slow But Steady
4/16/2025
While global momentum for DCTs accelerates, Japanese healthcare institutions face unique structural and operational hurdles to implement remote and digital trial activities.
-
Insights From A Digital Health Intervention Trial For Heart Failure
3/18/2025
University of Twente’s Mark Schuuring, MD, Ph.D. explores how digital health tools can successfully support heart failure interventions, despite hesitancy from providers and skepticism about the interest and abilities of a more senior patient population.
-
Social Media And A Site-Less Model Led This Trial To Pandemic-Era Success
3/10/2025
Genescopy's Chief Science and Medical Officer Erica Barnell, MD, Ph.D. explains how social media recruiting and a site-less trial design helped the company's CRC-PREVENT Phase 3 trial succeed.
-
In Clinical Research, Every Day Is Groundhog Day
1/30/2025
Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.
-
How AI Will Transform Health Equity In Clinical Trials In 2025
12/23/2024
Click Therapeutics' CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.